Shares of Adventrx Pharmaceuticals (ANX) plunged 58.27% to $1.06 today, the day after the biotech firm said the U.S. Food and Drug Administration has refused to approve its new lung-cancer drug Exelbine. Exelbine is a proprietary reformulation of the chemotherapy drug vinorelbine. Based on inspections of clinical trial sites, FDA reviewers were unable to verify […]
Home» Posts tagged "stock market losers"
Stereotaxis Inc. (STXS): Impending Bounce Play
Stereotaxis Inc. (Nasdaq: STXS) announced Monday after-hours that its loss in the second quarter widened to $9.7 million, compared with a loss of $3.9 million in the second quarter of 2010. The St. Louis medical device maker reported revenue of $11.6 million for the quarter ended June 30, down 23 percent from $15 million a […]